Literature DB >> 9880511

The hematopoietic transcription factor SCL binds the p44 subunit of TFIIH.

X F Zhao1, P D Aplan.   

Abstract

SCL is a basic domain helix-loop-helix (bHLH) oncoprotein that is involved in T-cell acute lymphoblastic leukemia as well as in normal hematopoiesis. Although it is believed that SCL functions as a tissue-specific transcription factor, no molecular mechanism has thus far been identified for this putative function. In this report, we show that SCL interacts with p44, a subunit of the basal transcription factor TFIIH. The minimal region of SCL that interacts with p44 was mapped to a 101-amino acid sequence that includes, but is not limited to, the bHLH region; the SCL-binding site of p44 is located in the carboxyl-terminal half of p44. This interaction was confirmed by glutathione S-transferase fusion protein pull-down assays and a co-immunoprecipitation assay. As analyzed with a yeast two-hybrid system, p44 interacts specifically with SCL, but not with the other class A or B bHLH proteins tested. E2A did not compete with p44 for SCL binding, as demonstrated by an in vitro binding assay. These findings document a previously unsuspected interaction between SCL and a subunit of the basal transcription factor TFIIH, suggesting a potential means by which SCL might modulate transcription.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9880511     DOI: 10.1074/jbc.274.3.1388

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.

Authors:  D S Chervinsky; X F Zhao; D H Lam; M Ellsworth; K W Gross; P D Aplan
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  SCL assembles a multifactorial complex that determines glycophorin A expression.

Authors:  Rachid Lahlil; Eric Lécuyer; Sabine Herblot; Trang Hoang
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.